Qimin Quan

Dr. Qimin Quan is co-founder and Chief Scientific Officer of NanoMosaic, a Boston-based biotechnology company to develop and leverage the power of nanoneedles for proteomics and multiomics. The nanoneedle technology alleviates the sensitivity, dynamic range and multiplexing bottlenecks in proteomics and provides an end-to-end solution that enables protein discovery and clinical assay development.

Prior to NanoMosaic, Dr. Quan is a PI and Rowland Fellow at Harvard University/Rowland Institute. He leads the Nanoscale Sensors and Systems Lab and developed the first nanoneedle sensors to monitor protein levels in living cells, and photonic resonator systems that detect protein-protein/DNA interaction in real time in its native state without labels or chemical amplifications.